Mirati Therapeutics, Inc.
MRTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $235 | $413 | $1,390 | $415 |
| Short-Term Investments | $849 | $1,078 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $2 |
| Inventory | $3 | -$3 | -$2 | -$2 |
| Other Curr. Assets | $21 | $17 | $14 | $9 |
| Total Curr. Assets | $1,109 | $1,508 | $1,404 | $424 |
| Property Plant & Equip (Net) | $54 | $54 | $48 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15 | $0 | $0 | $0 |
| Long-Term Investments | $3 | $8 | $16 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $22 | $19 | $9 | $6 |
| Total NC Assets | $94 | $81 | $72 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,203 | $1,589 | $1,476 | $432 |
| Liabilities | – | – | – | – |
| Payables | $39 | $35 | $18 | $48 |
| Short-Term Debt | $8 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$1 | $0 | $1 |
| Other Curr. Liab. | $113 | $108 | $53 | $0 |
| Total Curr. Liab. | $159 | $144 | $71 | $49 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $47 | $48 | $44 | $0 |
| Total NC Liab. | $47 | $48 | $44 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $206 | $192 | $115 | $50 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,453 | -$1,712 | -$1,130 | -$772 |
| AOCI | -$4 | $9 | $10 | $10 |
| Other Equity | $3,453 | $3,100 | $2,481 | $1,145 |
| Total Equity | $997 | $1,397 | $1,361 | $382 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,203 | $1,589 | $1,476 | $432 |
| Net Debt | -$227 | -$413 | -$1,390 | -$415 |